GLOBAL COLLABORATION AGREEMENT by and between ASTRAZENECA LP and THE MEDICINES COMPANY Dated as of April 25, 2012Global Collaboration Agreement • August 9th, 2012 • Medicines Co /De • Pharmaceutical preparations • Delaware
FIRST AMENDMENT TO GLOBAL COLLABORATION AGREEMENTGlobal Collaboration Agreement • March 3rd, 2014 • Medicines Co /De • Pharmaceutical preparations
THIS FIRST AMENDMENT TO GLOBAL COLLABORATION AGREEMENT (this “Amendment”) is made and entered into as of the 24th day of July, 2012 (the “Amendment Effective Date”), by and between AstraZeneca LP, a Delaware limited partnership (“AstraZeneca”), and The Medicines Company, a Delaware corporation (“MDCO”).
GLOBAL COLLABORATION AGREEMENT WITH HUTCHISON MEDIPHARMAGlobal Collaboration Agreement • June 12th, 2018
This announcement is made by Innovent Biologics, Inc. (the “Company”, together with its subsidiaries, the “Group”) on a voluntary basis to inform the shareholders of the Company and potential investors about the latest business updates of the Group.
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. SECOND AMENDMENT TO GLOBAL COLLABORATION AGREEMENTGlobal Collaboration Agreement • March 3rd, 2014 • Medicines Co /De • Pharmaceutical preparations
THIS SECOND AMENDMENT TO GLOBAL COLLABORATION AGREEMENT (this “Second Amendment”) is made and entered into as of the ___ day of December, 2013 (the “Second Amendment Effective Date”), by and between AstraZeneca LP, a Delaware limited partnership (“AstraZeneca”), and The Medicines Company, a Delaware corporation (“MDCO”).
